Stock 002004 HUAPONT LIFE SCIENCES CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Huapont Life Sciences Co.,Ltd

Equities

002004

CNE000001JJ6

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-21 pm EDT 		5-day change 1st Jan Change
4.5 CNY -0.44% Intraday chart for Huapont Life Sciences Co.,Ltd +0.22% -3.43%
Apr. 02 Tranche Update on Huapont Life Sciences Co.,Ltd's Equity Buyback Plan announced on December 28, 2023. CI
2023 Huapont Life Sciences Co.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares. CI

Business Summary

HUAPONT LIFE SCIENCES CO., LTD. is a China-based company principally engaged in the research and development, manufacture and sales of pesticide chemical products. The Company operates through three segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sales of skin pharmaceuticals, antituberculous pharmaceuticals and other manufactured products. Its products include fleroxacin and ambroxol hydrochloride for injection, and lecithin-bound iodine capsules, among others. The Pesticide Chemical segment is engaged in the production and sales of pesticides and other fine chemicals, including herbicides, bactericides and insecticides, among others. The Bulk Drug segment is engaged in the research and development and manufacture of bulk drugs and medical intermediates. The Company is also engaged in the provision of travel services, the sales of tea and the provision of technical services, among others.

Number of employees: 12,476

Sales per Business

CNY in Million2021Weight2022Weight Delta
Agrochemical New Materials
69.1 %
8,190 66.3 % 9,142 69.1 % +11.63%
Pharmaceutical
24.4 %
3,219 26.0 % 3,225 24.4 % +0.20%
Tourism
3.6 %
584 4.7 % 474 3.6 % -18.87%
Other
2.8 %
336 2.7 % 372 2.8 % +10.90%
Group Headquarters
0.1 %
31 0.3 % 19 0.1 % -38.92%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
59.1 %
7,702 62.3 % 7,814 59.1 % +1.45%
Foreign
40.9 %
4,657 37.7 % 5,418 40.9 % +16.35%

Managers

Managers TitleAgeSince
Hai An Zhang CEO
 Chief Executive Officer 43 18-09-30
Jian Wang DFI
 Director of Finance/CFO 48 14-01-09
Yun Hui Peng BRD
 Director/Board Member 60 01-08-31
Zhi Chen IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Song Shan Zhang CHM
 Chairman 63 01-08-31
Yun Hui Peng BRD
 Director/Board Member 60 01-08-31
Zhong Hai Liu BRD
 Director/Board Member 49 21-08-12
Rong Wang BRD
 Director/Board Member 52 12-02-02
Qiang Bian BRD
 Director/Board Member 52 10-10-06
Wen Xing Wang BRD
 Director/Board Member 43 11-12-31
Ming Li BRD
 Director/Board Member 60 21-08-12
Hai An Zhang CEO
 Chief Executive Officer 43 18-09-30
Zheng Jun Wang CHM
 Chairman 64 21-08-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,979,919,191 1,252,181,798 ( 63.24 %) 0 63.24 %

Shareholders

NameEquities%Valuation
Zhang Family
19.71 %
370,449,804 19.71 % 221 M ¥
Xiao Ming Dong
3.706 %
69,661,488 3.706 % 42 M ¥
Yi Zhuo Zhang
2.929 %
55,060,000 2.929 % 33 M ¥
Xue Ping Jiang
2.103 %
39,524,400 2.103 % 24 M ¥
Jun Tian Yu
1.756 %
33,000,000 1.756 % 20 M ¥
Song Shan Zhang
1.557 %
29,273,896 1.557 % 17 M ¥
City of Xi'an
0.8313 %
15,625,000 0.8313 % 9 M ¥
Wei Hu Yang
0.7573 %
14,235,118 0.7573 % 9 M ¥
Fullgoal Fund Management Co., Ltd.
0.5723 %
10,756,562 0.5723 % 6 M ¥
China Asset Management Co., Ltd.
0.2491 %
4,682,362 0.2491 % 3 M ¥
NameEquities%Valuation
Song Shan Zhang
87.61 %
87,821,687 87.61 % 52 M ¥
Rong Wang
10.77 %
10,800,000 10.77 % 6 M ¥

Holdings

NameEquities%Valuation
LIJIANG YULONG TOURISM CO., LTD.
29.99%
 164,808,890 29.99% 229,855,663 $

Company contact information

Huapont Life Sciences Co., Ltd.

No. 69 Renhe Xingguang Avenue Yubei District

401121, Chongqing

+86 23 6788 6900

http://www.huapont.com.cn
address Huapont Life Sciences Co.,Ltd(002004)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
HUAPONT LIFE SCIENCES CO.,LTD Stock Huapont Life Sciences Co.,Ltd
-3.43% 1.23B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.46% 659B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.57% 557B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.86% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.44% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.34% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.41% 215B
NOVARTIS AG Stock Novartis AG
+8.25% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.05% 200B
PFIZER, INC. Stock Pfizer, Inc.
-8.79% 149B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002004 Stock
  4. Company Huapont Life Sciences Co.,Ltd